Our Chairman has today welcomed the appointment of the Rt Hon Lord Andrew Feldman and Daryl Fielding - one of the UK's leading marketers - to our Board of Trustees.
The new trustees, who begin their tenure on 24 October, have been appointed to replace Richard Hytner and Dr Evan Harris, who have both served the maximum two three-year terms on our Board.
Lord Feldman will bring extensive legal, business and political experience to the Board. In his career to date, he has been in practice as a commercial barrister, Chief Executive of a manufacturing business and most recently Chairman of the Conservative Party.
Daryl Fielding will add significant business experience to the Board, having led the brand and marketing strategies for some of the world’s most recognisable brands, including Vodafone, The Independent and Mondelez.
UK's leading funder of CVD research
Our Chairman, Dr Doug Gurr, said: “Everyone at the BHF would like to thank Richard Hytner and Dr Evan Harris for their commitment to our fight against heart disease. Their leadership and insight has been instrumental in ensuring the BHF maintains the highest standards of governance, and it’s no coincidence that their tenure has coincided with the charity funding more world-class research than ever before.
“We’re excited to welcome Lord Feldman and Daryl Fielding to the Board. Their experience across commerce, marketing and politics will be invaluable in helping the BHF build on its position as the UK’s leading funder of cardiovascular research, enabling us to save more lives.”
Rt Hon Lord Feldman of Elstree said: “I am absolutely delighted to be joining the Board of the BHF at this very exciting time in their journey. Whether it’s funding breakthroughs in treatment, increasing the possibilities of early diagnosis, or supporting people living with a cardiovascular condition, the BHF is a world-class organisation at the forefront of the fight against cardiovascular disease.
“Having just passed the halfway mark in its 2020 Strategy, the BHF is in a very important phase of its mission and it is a great privilege to be able to make a contribution to its crucial, life-saving work.”
Daryl Fielding said: "The British Heart Foundation has made a big difference to many lives by funding research and, importantly, enabling its application. The impact of circulatory disease can be heartbreaking, as I know from personal experience. Charities are facing more and more challenges as marketing regulation changes and the digital landscape evolves, so I look forward to bringing my business and marketing expertise to help the charity go from strength to strength in the future."
Saving lives worldwide
Thanks to the donations and custom of our supporters, we are the UK's leading funder of cardiovascular research in the UK. Between 2015 and 2020, we aim to fund more than £500 million of research that could save and improve the lives of millions of people living with heart and circulatory disease in the UK, and worldwide.
Learn about our research strategy